Type 2 & other diabetes

Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes: a randomized controlled trial

Nat MedPublished Randomised controlled trial

Authors' conclusion

In conclusion, incorporating advice for meal timing with prolonged fasting led to greater improvements in postprandial glucose metabolism in adults at increased risk of developing type 2 diabetes.

Study context

Population
Adults at increased risk of developing T2D; 58 ± 10 years, BMI 34.8 ± 4.7 kg m-2
Participants
209 adults
Comparison
Intermittent fasting plus early time-restricted eating (iTRE) vs calorie restriction (CR) vs standard care
Primary endpoint
Change in glucose AUC in response to a mixed-meal tolerance test, iTRE vs CR
Follow-up
Month 6
Methodological detailsopen-label, parallel group, three-arm, randomized 2:2:1, Nutritional support to iTRE and CR for 6 months, with additional 12-month follow-up
  • Open-label
  • Parallel group
  • Three-arm
  • Randomized 2:2:1
  • Nutritional support to iTRE and CR for 6 months, with additional 12-month follow-up

Primary result

As reported in the abstract

Change in glucose AUC (mixed-meal tolerance test)

iTRE

−10.10

CI −14.08–-6.11 · mg dl-1 min-1

CR

−3.57

CI −7.72–0.57 · mg dl-1 min-1

P = 0.03

Further findings

Glucose tolerance, iTRE vs CR · month 18

Differences seen at month 6 were lost at month 18

Safety

Adverse events were transient and generally mild
Fatigue reports higher with iTRE vs CR and standard care
Constipation and headache reports higher with iTRE and CR vs standard care

Original publication

Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes: a randomized controlled trial. Nat Med. Published 6 April 2023. doi:10.1038/s41591-023-02287-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.